BOSTON--(BUSINESS WIRE)--Lumeon, a leader in care journey orchestration, today announced the appointment of John Glaser to the Lumeon Board of…
March 7, 2022Announcement no. 1 BioPorto announces intention to initiate a rights issue with expected gross proceeds of up to…
DEERFIELD, Ill., March 07, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA) (“Surgalign”), a global medical technology company focused…
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…
With The Inovalon Converged Solution, Health Plans Can More Efficiently and Effectively Predict and Resolve Comprehensive Care Needs for Members…
bioLytical Laboratories Inc. announced today that it is launching a new platform, iStatis, and has received Health Canada authorization for…
Announces integrations with multiple leading Electronic Health Record (EHR) systemsIntroduces a new solution to enable Remote Therapeutic Monitoring (RTM) by…
Imsidolimab GPP GALLOP Phase 2 16-week data presented at 2021 EADV Congress and Phase 3 GPP GEMINI-1 trial initiatedTop-line data…
WOBURN, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the…
Toronto, Ontario--(Newsfile Corp. - March 7, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company")…